EPAM SYSTEMS, INC.
EPAMEPAM Systems, Inc. (EPAM) is a global provider of software engineering and IT consulting services. Founded in 1993, the company specializes in digital platform engineering, product development, and digital and product design. EPAM serves industries such as financial services, travel and hospitality, healthcare, and technology, offering customized solutions to help organizations innovate and improve their digital capabilities.
Company News
U.S. stocks rebounded Thursday with the Nasdaq 100 leading gains on a semiconductor rally fueled by an Intel-Apple chip manufacturing partnership. Oil prices tumbled 2.2% to $75/barrel following a U.S.-Iran peace deal and Strait of Hormuz reopening. The S&P 500 rose 1.2% while the Russell 2000 fell 0.7% amid mixed market performance.
Owls Nest Partners IA liquidated its entire 230,246-share position in EPAM Systems for approximately $39.37 million as the stock declined 43% over the past year. Despite EPAM showing operational improvements in Q1 2026 with 7.6% revenue growth and raised full-year guidance, the fund chose to exit entirely rather than wait for recovery.
Blue Door Asset Management added 88,100 shares of NICE (valued at $10.64 million) in Q4 2025, bringing its total position to 142,900 shares worth $16.15 million. Despite NICE stock declining 16.5% over the past year, the company showed strong fundamentals with 8% revenue growth to $2.95 billion, 13% cloud segment expansion, and 43% EPS growth in ...
Despite Waystar's stock declining 31.5% over the past year, Blue Door Asset Management purchased 322,600 shares worth $11.49 million in the latest quarter. The healthcare software company reported strong fundamentals with $1.10 billion in revenue (up 17% YoY) and adjusted EBITDA of $462 million (up 21% YoY), suggesting institutional confidence de...
Pomerantz Law Firm is investigating potential securities fraud claims against EPAM Systems following the company's disclosure on February 19, 2026 that its largest NEORIS customer is ramping down business. The announcement triggered a 6.61% stock price decline ($9.20 per share) over two trading sessions. The firm is also investigating similar cla...
